Reuters logo
BRIEF-Azurrx reaches 6th patient enrollment of midstage trial for pancreas drug
August 23, 2017 / 12:17 PM / a month ago

BRIEF-Azurrx reaches 6th patient enrollment of midstage trial for pancreas drug

Aug 23 (Reuters) - Azurrx Biopharma Inc

* Azurrx reaches 6th patient enrollment of Phase IIA trial of MS1819 for treatment of exocrine pancreatic insufficiency associated with chronic pancreatitis

* Azurrx Biopharma Inc- ‍results on first six patients expected in September from phase IIA trial of MS1819​

* Azurrx Biopharma Inc- added additional clinical trial site to further support enrollment in study and other planned future studies Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below